Kristin Baker Spohn
General Partner at BAM Elevate
San Francisco Bay Area
Overview
Work Experience
General Partner
2023 - Current
BAM Elevate is a growth equity fund that invests in breakout companies in transformational industries.
Lecturer in Management
2022
Teaching team for Startup Garage.
General Partner
2019 - 2023
Led investments in health tech for CRV including Viz.ai (Series B), Wheel (Series A), Power (Seed).
CRV is a venture capital firm that invests in investments in technology companies.
Partner
2017 - 2018
Board of directors: Propeller Health, Simplee, Glooko
We make big bets on transformational ideas, technology, and people.
Chief Commercial Officer
2014 - 2017
Joined pre-Series A and scaled through Series D. Led the go-to-market: built and led Sales, Client Success, and BD functions.
Collective Health is a modern TPA integrating plan admin, navigation and advocacy to deliver a better health benefits experience for all.
Raised $719,000,000.00 from DFJ Growth, G Squared, PFM Health Sciences, Sand Hill Angels, Health Care Service Corporation, New Enterprise Associates, Anchor Capital GP, Maverick Ventures, Sun Life Financial and The Capital Partnership.
Business Development, Finance & IR
2010 - 2014
Joined Castlight pre-Series A and scaled through IPO. Head of Finance and IR through Castlight's IPO in 2014, Director of Business Development 2010 - 2013.
Castlight Health provides a healthcare navigation platform with resources for benefits, and vendors.
Raised $184,099,999.00 from Venrock, T. Rowe Price, Morgan Stanley, Wellcome Trust, Maverick Ventures, U.S. Venture Partners, Employee Stock Option Fund and Oak Investment Partners.
Health IT Investment Committee
2008 - 2010
Strategic Planning
2009 - 2009
Onyx Pharmaceuticals is a biopharmaceutical company committed to improving the lives of people with cancer.
Raised $20,000,000.00 from OrbiMed, Perceptive Life Sciences, Federated Kaufmann Fund and Domain Associates.
Market Planning, BioOncology
2009 - 2009
Genentech specializes in genetic testing and personalized medicine.
Investment Banking, Healthcare Group
2005 - 2008
Executed M&A and financing transactions for biotech, medical device, healthcare technology and life sciences companies including Genentech/Roche, Anormed/Genzyme, Illumina, athenahealth, Amgen.
Goldman Sachs is a multinational financial services firm providing securities, investment banking, and management services.